Clinical prospects proposing an increase in the luteolytic dose of prostaglandin F2α in dairy cattle

Autor/a

López Gatius, Fernando

Data de publicació

2021-03-23T13:45:57Z

2021-03-23T13:45:57Z

2021



Resum

Over the past few decades, the luteolytic dose of prostaglandin F2α (PGF2α) and its analogs, used to synchronize estrus for fixed-time insemination in dairy cattle, have remained unchanged. Given the beneficial effects of PGF2α on a young corpus luteum and on multiple ovulations in a fixed-time insemination protocol, and its therapeutic abortive effects on multiple ovulations in pregnant cows, we propose the use of a double PGF2α dose or two PGF2α treatments 24 hours apart. Ultrasonography procedures serve to identify luteal structures and may therefore help to determine the best PGF2α dose to improve the fertility of high-producing dairy cows.

Tipus de document

Article
Versió publicada

Llengua

Anglès

Matèries i paraules clau

Additional corpora lutea; Cloprostenol; Double ovulation; Fixed-time artificial insemination (FTAI); Twin pregnancy

Publicat per

The Society for Reproduction and Development

Documents relacionats

Reproducció del document publicat a: https://doi.org/10.1262/jrd.2020-101

Journal of Reproduction and Development, 2021, vol. 67, núm. 1, p. 1-3

Drets

cc-by-nc-nd (c) The Society for Reproduction and Development, 2021

https://creativecommons.org/licenses/by-nc-nd/4.0/

Aquest element apareix en la col·lecció o col·leccions següent(s)